Manik L. Debnath

10.0k total citations · 3 hit papers
40 papers, 4.2k citations indexed

About

Manik L. Debnath is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Manik L. Debnath has authored 40 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Computational Theory and Mathematics. Recurrent topics in Manik L. Debnath's work include Alzheimer's disease research and treatments (27 papers), Computational Drug Discovery Methods (11 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Manik L. Debnath is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Computational Drug Discovery Methods (11 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Manik L. Debnath collaborates with scholars based in United States, Japan and Armenia. Manik L. Debnath's co-authors include William E. Klunk, Chester A. Mathis, Guo-Feng Huang, Daniel P. Holt, Yanming Wang, Miloš D. Ikonomović, Steven T. DeKosky, Matthew P. Frosch, Bradley T. Hyman and Eric E. Abrahamson and has published in prestigious journals such as Journal of Neuroscience, NeuroImage and Brain.

In The Last Decade

Manik L. Debnath

40 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis and Evaluation of ¹¹C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents

2003 828 citations Chester A. Mathis, Yanming Wang et al. Journal of Medicinal Chemistry profile →
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

2008 681 citations Miloš D. Ikonomović, William E. Klunk et al. profile →
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

2015 450 citations William E. Klunk, Chester A. Mathis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manik L. Debnath United States	19	3.1k	1.4k	987	879	537	40	4.2k
Vladimir Kepe United States	34	2.5k 0.8×	1.3k 0.9×	1.2k 1.2×	893 1.0×	682 1.3×	91	4.9k
Daniel P. Holt United States	29	2.3k 0.8×	1.4k 1.0×	1.1k 1.2×	1.5k 1.7×	794 1.5×	98	5.4k
Yukitsuka Kudo Japan	32	2.0k 0.7×	874 0.6×	715 0.7×	608 0.7×	331 0.6×	110	3.1k
Shozo Furumoto Japan	35	2.0k 0.7×	943 0.7×	857 0.9×	1.0k 1.2×	475 0.9×	141	4.0k
Sergey Shcherbinin United States	23	1.9k 0.6×	1.1k 0.8×	617 0.6×	609 0.7×	364 0.7×	95	3.1k
Rachel S. Mulligan Australia	33	2.1k 0.7×	1.9k 1.3×	686 0.7×	836 1.0×	803 1.5×	82	4.2k
Guo-Feng Huang United States	10	1.7k 0.6×	710 0.5×	606 0.6×	555 0.6×	265 0.5×	10	2.5k
Michelle T. Fodero‐Tavoletti Australia	24	1.7k 0.6×	729 0.5×	776 0.8×	455 0.5×	305 0.6×	47	2.7k
Daniel Skovronsky United States	40	5.4k 1.8×	3.2k 2.3×	1.8k 1.8×	1.6k 1.8×	1.1k 2.1×	85	8.2k
Tobias Bittner Switzerland	26	2.5k 0.8×	1.6k 1.1×	882 0.9×	179 0.2×	341 0.6×	56	3.8k

Countries citing papers authored by Manik L. Debnath

Since Specialization

Citations

This map shows the geographic impact of Manik L. Debnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manik L. Debnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manik L. Debnath more than expected).

Fields of papers citing papers by Manik L. Debnath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manik L. Debnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manik L. Debnath. The network helps show where Manik L. Debnath may publish in the future.

Co-authorship network of co-authors of Manik L. Debnath

This figure shows the co-authorship network connecting the top 25 collaborators of Manik L. Debnath. A scholar is included among the top collaborators of Manik L. Debnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manik L. Debnath. Manik L. Debnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stehouwer, Jeffrey S., Guofeng Huang, Manik L. Debnath, et al.. (2025). Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers. Journal of Medicinal Chemistry. 68(6). 6462–6492. 1 indexed citations

Ikonomović, Miloš D., Eric E. Abrahamson, Julie C. Price, et al.. (2012). Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathologica. 123(3). 433–447. 68 indexed citations

Lin, Kuo‐Shyan, Manik L. Debnath, Chester A. Mathis, & William E. Klunk. (2009). Synthesis and β-amyloid binding properties of rhenium 2-phenylbenzothiazoles. Bioorganic & Medicinal Chemistry Letters. 19(8). 2258–2262. 31 indexed citations

Ikonomović, Miloš D., Eric E. Abrahamson, Barbara A. Isanski, et al.. (2006). X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease. Methods in enzymology on CD-ROM/Methods in enzymology. 123–144. 45 indexed citations

Klunk, William E., Brian J. Lopresti, Miloš D. Ikonomović, et al.. (2005). Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain. Journal of Neuroscience. 25(46). 10598–10606. 294 indexed citations

Matsuoka, Yasuji, Shao Li, Manik L. Debnath, et al.. (2005). An Aβ Sequestration Approach Using Non-Antibody Aβ Binding Agents. Current Alzheimer Research. 2(2). 265–268. 7 indexed citations

Wang, Yanming, William E. Klunk, Manik L. Debnath, et al.. (2004). Development of a PET/SPECT Agent for Amyloid Imaging in Alzheimer's Disease. Journal of Molecular Neuroscience. 24(1). 55–62. 63 indexed citations

Mathis, Chester A., Yanming Wang, Daniel P. Holt, et al.. (2003). Synthesis and Evaluation of ¹¹C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents. Journal of Medicinal Chemistry. 46(13). 2740–2754. 828 indexed citations breakdown →

Mathis, Chester A., Brian J. Bacskai, Stephen T. Kajdasz, et al.. (2002). A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorganic & Medicinal Chemistry Letters. 12(3). 295–298. 282 indexed citations

10.

Wang, Yanming, William E. Klunk, Guo-Feng Huang, et al.. (2002). Synthesis and evaluation of 2-(3′-lodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in alzheimer’s disease. Journal of Molecular Neuroscience. 19(1-2). 11–16. 42 indexed citations

11.

Klunk, William E., Brian J. Bacskai, Chester A. Mathis, et al.. (2002). Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative. Journal of Neuropathology & Experimental Neurology. 61(9). 797–805. 320 indexed citations

12.

Klunk, William E., et al.. (2001). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sciences. 69(13). 1471–1484. 377 indexed citations

13.

Wang, Yadong, William E. Klunk, Guay‐Fen Huang, et al.. (2001). Synthesis and evaluation of a radioiodinated benzothiazole derivative as a radioligand for in vivo quantitation of β‐amyloid deposits in aging and alzheimer's disease. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 4 indexed citations

14.

Mathis, Chester A., et al.. (2001). Lipophilic ¹¹C‐labelled thioflavin‐T analogues for imaging amyloid plaques in alzheimer's disease. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 13 indexed citations

15.

Klunk, William E., Yanming Wang, Manik L. Debnath, Daniel P. Holt, & Chester A. Mathis. (2000). X-34 and other congo red-type amyloid binding agents as in vivo amyloid probes. Neurobiology of Aging. 21. 21–21. 2 indexed citations

16.

Hall, Iris H., et al.. (1997). Synthesis and Cytotoxic Action of 3,5‐Isoxazolidinediones and 2‐Isoxazolin‐5‐ones in Murine and Human Tumors. Archiv der Pharmazie. 330(3). 67–73. 9 indexed citations

17.

Debnath, Manik L., et al.. (1995). Investigation of 3,5-Isoxazolidinediones as Hypolipidemic Agents in Rodents. Pharmaceutical Research. 12(1). 24–38. 9 indexed citations

18.

Klunk, William E., Manik L. Debnath, & Jay W. Pettegrew. (1994). Small molecule beta-amyloid probes which distinguish homogenates of Alzheimer's and control brains. Biological Psychiatry. 35(9). 627–627. 14 indexed citations

19.

Klunk, William E., Manik L. Debnath, & Jay W. Pettegrew. (1994). Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease. Neurobiology of Aging. 15(6). 691–698. 146 indexed citations

20.

Izydore, Robert A., et al.. (1992). The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells. Anti-Cancer Drugs. 3(3). 273–280. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact